Dramatic volume reduction of a large GH/TSH secreting pituitary tumor with short term Octreotide therapy.
A case is presented of a huge GH/TSH secreting tumor and marked volumetric reduction in size with only one week of Octreotide therapy. To our knowledge, this is the first reported case of such a dramatic volumetric response to short-term Octreotide therapy.
Atkinson
John L D
JL
Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota 55905, USA. atkinson.john@mayo.edu
Abboud
Charles F
CF
Lane
John I
JI
D005260:Female; D019382:Human Growth Hormone / Q000378:metabolism*; D006801:Humans; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D013972:Thyrotropin / Q000378:metabolism*
D019382:Human Growth Hormone; D013972:Thyrotropin; D015282:Octreotide